Gene-expression signatures of nasal polyps associated with chronic rhinosinusitis and aspirin-sensitive asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 9, Issue 1, 2009, Pages 23-28

  Platt, Michael ^a   Metson, Ralph ^b   Stankovic, Konstantina ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Aspirin sensitive asthma; Chronic rhinosinusitis; Expression signatures; Gene expression profiling; Microarray; Nasal polyps

Indexed keywords

ACETYLSALICYLIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PP1R9B; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ASTHMA; CHRONIC SINUSITIS; DISEASE ASSOCIATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; MICROARRAY ANALYSIS; NOSE POLYP; PRIORITY JOURNAL; REVIEW;

ASPIRIN; ASTHMA; CHRONIC DISEASE; DRUG HYPERSENSITIVITY; GENE EXPRESSION PROFILING; HUMANS; NASAL POLYPS; RHINITIS; SINUSITIS;

EID: 58849164762     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32831d8170     Document Type: Review

References (54)

1. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 2004; 193:3-5.
2. National Institute of Allergies and Infectious Diseases, US Department of Health and Human Services; 2006. http://www.niaid.nih.gov/factsheets/sinusitis. htm.
3. Gliklich RE, Metson R. Economic implications of chronic sinusitis. Otolaryngol Head Neck Surg 1998; 118:344-349.
4. Bateman ND, Fahy C, Woolford TJ. Nasal polyps: still more questions than answers. J Laryngol Otol 2003; 11 7:1 -9.
5. Nevins JR, Potti A. Mining gene expression profiles: expression signatures as cancer phenotypes. Nat Rev Genet 2007; 8:601 -609. This is an outstanding review article that explains the power of gene expression profiling in defining expression signatures to dissect the complexity of cancer phenotypes, and ultimately to discover the mechanisms that underlie cancer.
6. Wang X, Dong Z, Zhu DD, Guan B. Expression profile of immune-associated genes in nasal polyps. Ann Otol Rhinol Laryngol 2006; 115:450-456.
7. Figueiredo CR, Santos RP, Silva ID, Weckx LL. Microarray cDNA to identify inflammatory genes in nasal polyposis. Am J Rhinol 2007;21:231-235.
8. Bolger WE, Joshi AS, Spear S, et al. Gene expression analysis in sinonasal polyposis before and after oral corticosteroids: a preliminary investigation. Otolaryngol Head Neck Surg 2007; 137:27-33.
9. Orlandi RR, Thibeault SL, Ferguson BJ. Microarray analysis of allergic fungal sinusitis and eosinophilic mucin rhinosinusitis. Otolaryngol Head Neck Surg 2007; 136:707-713.
10. Fritz SB, Terrell JE, Conner ER, et al. Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polyps. J Allergy Clin Immunol 2003; 112:1057-1063.
11. Liu Z, Kim J, Sypek JP, et al. Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol 2004; 114:783-790.
12. Benson M, Carlsson L, Adner M, et al. Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps. J Allergy Clin Immunol 2004; 113:1137-1143.
13. Liu B, Wu J, Fan J, Peng Y. Gene expression profiles in human nasal polyps studied by DNA microarray [in Chinese]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2008; 22:495-497.
14. Stankovic KM, Goldsztein H, Reh DD, et al. Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma. Laryngoscope 2008; 118:881 -889. This article used genome-wide expression profiling of sinonasal tissue from 30 patients to identify genes whose expression is most characteristic of CRS and ASA.
15. Norris RA, Damon B, Mironov V, et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 2007; 101:695-711.
16. Kuhn B, del Monte F, Hajjar R, et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nature Med 2007; 13:962-969.
17. Shao R, Bao S, Bai X, et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 2004;24:3992-4003; 2004.
18. Woodruff PG, Boushey HA, Dolganov GM, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Nat Acad Sci U S A 2007; 104:15858-15863. This study used gene-expression profiling to identify alterations in airway epithelial cells in asthmatics. Periostin, which has also been implicated in nasal polyps, was found to be upregulated in asthmatics and predicted good clinical response to corticosteroids.
19. Krouse JH, Veling MC, Ryan MW, et al. Executive summary: asthma and the unified airway. Otolaryngol Head Neck Surg 2007; 136:699-706. This is an excellent review that highlights the similarities in epithelial linings, biological functions, and disease processes that affect the upper and lower airways.
20. Park M, Dean M, Kaul K, et al. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci U S A 1987; 84:6379-6383.
21. Sattler M, Salgia R. c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy. Curr Oncol Rep 2007; 9:102-108.
22. Gentile A, Trusolino L, Comoglio PM. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 2008; 27:85-94.
23. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4:915-925.
24. Maina F, Casagranda F, Audero E, et al. Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development. Cell 1996;87:531-542.
25. Weidner KM, Di Cesare S, Sachs M, et al. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 1996; 384:173-176.
26. Ma PC, Kijima T, Maulik G, et al. c-MET mutational analysis on small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Cancer Res 2003; 63:6272-6281.
27. Maulik G, Shrikhande A, Kijima T, et al. Role of the hepatocyte growth factor receptor c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 2002; 13:41 -59.
28. Chen J, Lin T, Chow K, et al. Cigarette smoking induces overexpression of hepatocyte growth factor in type II pneumocytes and lung cancer cells. Am J Respir Cell Mol Biol 2006; 24:264-273.
29. Wang X, Le P, Liang C, et al. Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. Mol Cancer Ther 2003; 2:1085-1092.
30. Nakanishi H, Obaishi H, Satoh A, et al. Neurabin: a novel neural tissue-specific actin filament-binding protein involved in neurite formation. J Cell Biol 1997;139:951-961.
31. Watanabe T, Huang HB, Horiuchi A, et al. Protein phosphatase 1 regulation by inhibitors and targeting subunits. Proc Natl Acad Sci U S A 2001;98:3080-3085.
32. Wang QP, Escudier E, Thoraval FR, et al. Myofibroblast accumulation induced by transforming growth factor-B is involved in pathogenesis of nasal polyps. Laryngoscope 1997; 107:926-931.
33. Gil-Guerrero L, Dotor J, Huibregtse IL, et al. In vitro and in vivo down regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1. J Immunol 2008; 181:126-135.
34. Bhattacharyya N, Vyas DK, Fechner FP, et al. Tissue eosinophilia in chronic sinusitis: quantification techniques. Arch Otolaryngol Head Neck Surg 2001;127:1102-1105.
35. Danielsen A, Tynning T, Brokstad KA, et al. Interleuken 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa, and serum. Eur Arch Otolrhinolaryngol 2006; 263:282-289.
36. Patou J, Gevaert P, Van Zele T, et al. Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 2008; 121:110-115. This study examined the role of Staphylococcus aureus in altering cytokines and chemical mediators in CRS. The presented data support the theory that stimulatory superantigens contribute to the development of nasal polyposis.
37. Molet S, Hamid Q, Davione F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108:430-438.
38. Wright ED, Frenkiel S, Al-Ghamdi K, et al. lnterleukin-4, interleukin-5, and granulocyte-macrophage colony-stimulating factor receptor expression in chronic sinusitis and response to topical steroids. Otolaryngol Head Neck Surg 1998; 118:490-495.
39. Jutel M, Akdis CA. T-cell regulatory mechanisms in specific immunotherapy. Chem Immunol Allergy 2008; 94:158-177.
40. Otto BA, Wenzel SE. The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr Opin Otolaryngol Head Neck Surg 2008; 16:270-274. This review article summarizes the role of cytokines in CRS associated with nasalpolyps.
41. Gaubin M, Autiero M, Basmaciogullari S, et al. Potent inhibition of CD4/TCR- mediated T cell apoptosis by a CD4-binding glycoprotein secreted from breast tumor and seminal vesicle cells. J Immunol 1999; 162:2631 -2638.
42. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994; 91:6259-6263.
43. Aguila A, Herrar AG, Morrison D, et al. Bacteriostatic activity of human lactoferrin against Staphylococcus aureus is a function of its iron-binding properties and is not influenced by antibiotic resistance. FEMS Immunol Med Microbiol 2001; 31:145-152.
44. Wang X, Vertino A, Eddy RL, et al. Chromosome mapping and organization of the human beta-galactoside alpha-2,6-sialyltransferase gene: differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells. J Biol Chem 1993; 268:4355-4361.
45. Singh G, Katyal SL. Clara cell proteins. Ann NY Acad Sci 2000; 923:43-58.
46. Hassan Ml, Waheed A, Yadav S, et al. Zinc alpha 2-glycoprotein: a multi disciplinary protein. Mol Cancer Res 2008; 6:892-906.
47. Bing C, Bao Y, Jenkins J, et al. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci U S A 2004; 101:2500-2505.
48. Cole AM, Dewan P, Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun 1999; 67:3267-3275.
49. Watson MA, Darrow C, Zimonjic DB, et al. Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11 q13. Oncogene 1998; 16:817-824.
50. Kundu GC, Mantile G, Miele L, et al. Recombinant human uteroglobin suppresses cellular invasiveness via a novel class of high-affinity cell surface binding site. Proc Natl Acad Sci U S A 1996; 93:2915-2919.
51. Heyns W, Bossyns D. A comparative study of estramustine and pregnenolone binding to prostatic binding protein: evidence for subunit cooperativity. J Steroid Biochem 1983; 19:1689-1694.
52. Richer SL, Truong-Tran AQ, Conley DB, et al. Epithelial genes in chronic rhinosinusitis with and without nasal polyps. Am J Rhinol 2008; 22:228-234.
53. Ramanathan M Jr, Lee WK, Dubin MG, et al. Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps. Am J Rhinol 2007; 21:110-116.
54. Al-Shemari H, Bosse Y, Hudson TJ, et al. Influence of leukotriene gene polymorphisms on chronic rhinosinusitis. BMC Med Genet 2008; 9:21.